The first VIPD portfolio company established to commercialize a VIPD-evaluated technology is algorithmRx, LLC. Its initial product, Statin Manager, is a unique decision-support tool to help clinicians select the most effective statin, in the right dosage, for each hypercholesterolemic patient the first time, every time.

algorithmRx, LLC is majority-owned by Venebio, in partnership with Stephen Hutcherson, an experienced and successful serial entrepreneur in the pharmaceutical industry. The vision for algorithmRx, LLC is to offer a suite of algorithm-based decision-support tools to help clinicians select and prescribe the most efficacious medication regimen for a variety of human diseases.